Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Photobiomodulation Therapy for the Management of Chemotherapy-induced Alopecia: a Randomized, Placebo-controlled Feasibility Trial

NCT04036994 is registered in ClinicalTrials.gov with Hasselt University as lead sponsor.

NCT NCT04036994
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04036994 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Photobiomodulation Therapy for the Management of Chemotherapy-induced Alopecia: a Randomized, Placebo-controlled Feasibility Trial
Lead sponsor
Hasselt University
Phase
Not applicable
Overall status
Unknown status
Start date
June 17, 2020
Completion date
December 31, 2022
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alopecia, breast cancer, chemotherapy-induced alopecia